@FiercePharma: Conquering the complexities of biologics to get to biosimilars. Special report | Follow @FiercePharma
@EricPFierce: Alexion files 8-K saying FDA is not impressed with its manufacturing at its Rhode Island plant. 8-K filing | Follow @EricPFierce
> U.K. cost-effectiveness watchdogs gave their final approval to cystic fibrosis drugs from Novartis ($NVS) and Forest Laboratories ($FRX). Report
> China's biggest drug distributor, Sinopharm, plans to raise up to $515 million by selling Hong Kong shares, aiming to expand its distribution and retail network. Report
> Pfizer ($PFE) settled a lawsuit with a Boulder, CO, couple who had sued over the death of their dog, Sophie, which was given the drug Rimadyl after surgery. Report
> Novartis will sell off part of its stake in an Indian subsidiary to meet Securities and Exchange Board requirements for minimum public shareholding in listed companies. Report
@FierceMedDev: CMO adds 200 medical device jobs in Ireland. Report | Follow @FierceMedDev
@MarkHFierce: A new FMD feature--this week in FDA med tech violations, the device industry's police blotter. More | Follow @MarkHFierce
@DamianFierce: Abbott won the FDA's OK for a diagnostic that detects birth defects and testicular cancer progress. News | Follow @DamianFierce
> U.K.'s Consort Medical mulls Dx expansion. Report
> Bacterin 2012 revenue climbs but losses also grow. Item
Biotech News
@FierceBiotech: From FierceBiotechResearch.com: New drug could combat resistant #malaria strains. Story | Follow @FierceBiotech
@JohnCFierce: 3 yrs after its first CRL, A.P. Pharma gets another. Insists it can do a quick turnaround, but wrong again on FDA: News | Follow @JohnCFierce
@RyanMFierce: With big RNA deal, AstraZeneca's Soriot signals yen for risky science. More | Follow @RyanMFierce
> Connecticut pols stunned as Pfizer brings in the wrecking ball. Item
> Repros shares boom on promising PhIII results for testosterone drug. Report
> Biogen Idec rolls up FDA OK for blockbuster multiple sclerosis drug Tecfidera. News
Vaccines News
> GSK vaccine plant helps U.S. arm for biodefense. Report
> Taboo topics: Sex, politics, religion... and vaccines? Article
> Swedish study adds to data linking GSK vax to narcolepsy. Item
> FDA moves decision day for GSK pandemic vaccine, but why? More
Pharma Manufacturing News
> Alexion gets warning letter for Soliris plant. Report
> FDA lifts ban on some Aurobindo antibiotics. News
> Injection point: BD, Teva, Hikma target sterile injectables. Story
> GSK gets OK for $91M vaccine plant with Texas A&M. Article
And Finally... Is modern life too cozy for our inborn survival instincts? Report